Amanote Research
Register
Sign In
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome
Cancers
- Switzerland
doi 10.3390/cancers11091219
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
August 21, 2019
Authors
Unknown
Publisher
MDPI AG
Related search
Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer
Cancer Research
Cancer Research
Oncology
Inhibitor of Differentiation-1 (Id1) Sustains Mutant KRAS-driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network
Cancer Research
Cancer Research
Oncology
Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Stat3 Promotes Metastatic Progression of Prostate Cancer
American Journal of Pathology
Forensic Medicine
Pathology
Activation of STAT3 in Human Gastric Cancer Cells via Interleukin (IL)-6-Type Cytokine Signaling Correlates With Clinical Implications
PLoS ONE
Multidisciplinary
circRIP2 Accelerates Bladder Cancer Progression via miR-1305/Tgf-β2/smad3 Pathway
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
CircRNA circRNA_102171 Promotes Papillary Thyroid Cancer Progression Through Modulating CTNNBIP1-dependent Activation of Β-Catenin Pathway
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
P53-Regulated Long Non-Coding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling
American Journal of Pathology
Forensic Medicine
Pathology
Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells
Molecular and Cellular Biology
Cell Biology
Molecular Biology
